Cellectis (CLLS) Short term Debt (2015 - 2026)

Cellectis (CLLS) posted quarterly Short term Debt of $8.9 million for Q1 2026, down 46.96% year-over-year from $16.8 million in Q1 2025, and down 14.88% quarter-over-quarter from $10.5 million in Q4 2025.

Cellectis (CLLS) Short term Debt (2015 - 2026) Analysis & Trends

Cellectis' Short term Debt history runs 12 years deep, the most recent figure standing at $8.9 million for Q1 2026.

  • In Q1 2026, Short term Debt fell 46.96% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $8.9 million (down 46.96% YoY), while the FY2025 annual figure was $10.5 million, down 35.17% from the prior year.
  • Short term Debt for Q1 2026 stood at $8.9 million, down from $10.5 million in the prior quarter.
  • The five-year high for Short term Debt was $18.2 million in Q3 2025, with the low at $5.1 million in Q3 2023.
  • The 5-year median for Short term Debt is $8.9 million (2026), against an average of $9.7 million.
  • The sharpest annual moves came in 2023 and 2025: Short term Debt sank 58.85% in 2023, then soared 256.12% in 2025.
  • Cellectis' Short term Debt stood at $5.1 million in 2022, then climbed by 3.95% to $5.3 million in 2023, then jumped by 205.05% to $16.1 million in 2024, then slumped by 35.17% to $10.5 million in 2025, then dropped by 14.88% to $8.9 million in 2026.
  • Business Quant data shows CLLS's Short term Debt at $8.9 million in Q1 2026, $10.5 million in Q4 2025, and $18.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Cellectis 306.61 Mn 120.95 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 8.90 Mn
Dec 31, 2025 10.46 Mn
Sep 30, 2025 18.24 Mn
Jun 30, 2025 18.23 Mn
Mar 31, 2025 16.79 Mn
Dec 31, 2024 16.13 Mn
Sep 30, 2024 5.35 Mn
Jun 30, 2024 5.12 Mn
Mar 31, 2024 5.17 Mn
Dec 31, 2023 5.29 Mn
Sep 30, 2023 5.06 Mn
Jun 30, 2023 5.19 Mn
Mar 31, 2023 5.19 Mn
Dec 31, 2022 5.09 Mn
Sep 30, 2022 10.38 Mn
Jun 30, 2022 11.31 Mn
Mar 31, 2022 12.61 Mn
Dec 31, 2021 2.35 Mn
Jun 30, 2020 3.78 Mn
Dec 31, 2019 1.07 Mn